Chemclin Diagnostics Co., Ltd.

Chemclin Diagnostics Co., Ltd (Chemclin Diagnostics), is a clinical laboratory pioneer specialized in the research and development, production, sales and services of In vitro diagnostic products in China. Chemclin Diagnostics (Shanghai) Co., Ltd, is a wholly-owned subsidiary of Chemclin Diagnostics. Light-initiated Chemiluminescence Immunoassay (LiCA) is our proprietary, innovative and highly sensitive homogeneous immunoassay technology, which integrates various cutting-edge advancements, such as, nanoparticle polymers, light-initiated chemiluminescent signaling technology and the unique wash-free immunoassay technique. Driven by the core value of "Serving human health through innovation", Chemclin Diagnostics developed the fully automated systems and assays (LiCA series) based on LiCA technology. LiCA series allows non-wash assay protocols which significantly simplifies the operational procedures and creatively solved the problem of detection error, may be caused by multi-step cleaning of the traditional systems with heterogeneous immunoassay technology. LiCA series has quickly become the favorite of thousands of laboratories given its excellent assay performance, easy operation, high throughput and minimum maintenance requirements. “Customer Focused, Quality Valued, Innovation Driven, and Result Oriented” are always the operation principles of the company. Chemclin Diagnostics is committed to providing innovative, more cost-effective products to the clinical medical laboratories in China as well as other countries around the world.